InvestorsHub Logo
Post# of 251673
Next 10
Followers 827
Posts 119535
Boards Moderated 15
Alias Born 09/05/2002

Re: Titan V post# 213705

Monday, 09/18/2017 3:12:46 PM

Monday, September 18, 2017 3:12:46 PM

Post# of 251673
Venclexta data in rrCLL—>modest negative for TEVA/EGRX insofar as the comparator arm in the trial in question was Treanda/Rituxan.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.